TOMSK, RUSSIA / RankWire.AI / – Russian researchers have successfully created and evaluated a bioactive layer designed for titanium orthopedic implants. This innovative material incorporates calcium phosphate derived from hydroxyapatite and features nitrogen compounds associated with nitric oxide production. Laboratory investigations revealed that human mesenchymal stem cells exhibited notably higher viability on coated titanium surfaces compared to uncoated metal. The study also explored surface chemistry, hardness, thickness, and wettability, with a peer-reviewed publication emphasizing how variations in gas mixtures altered the coating’s properties and its biological effects.
At Tomsk Polytechnic University, scientists produced these coatings using reactive magnetron sputtering within a vacuum chamber, employing a hydroxyapatite target while fine-tuning nitrogen and argon gas ratios during deposition. Five different gaseous conditions, including pure nitrogen and pure argon, were tested, each resulting in measurable modifications to the coating’s characteristics. Researchers analyzed surface structure, chemical composition, mechanical strength, and liquid contact angle, then exposed the coated titanium samples to human mesenchymal stem cells under controlled conditions to assess biological response.
The findings indicated that argon concentration significantly affected several physical properties; samples deposited with higher argon content became thicker, denser, and harder. Chemical analysis confirmed the presence of nitrogen-carbon and nitrogen-oxygen bonds within the modified surfaces. When comparing cell survival, the coated samples demonstrated a markedly increased support for cell viability over untreated titanium. The team also monitored gene activity related to early osteoblast differentiation to better understand how the coatings influenced cell behavior at the molecular level.
Enhanced cell viability observed on coated titanium surfaces
The researchers observed that increased nitrogen incorporation altered the expression of certain genes linked to early bone-cell development, with these effects becoming evident after seven days of cell growth. Despite these molecular changes, the cells retained their capacity to produce bone tissue. The study remains at the laboratory level and did not include testing in humans, nor did it measure clinical outcomes from actual implant procedures. Therefore, the results are limited to laboratory performance and biological responses, without direct evidence of benefits in clinical settings for joint replacements or other orthopedic devices.
The collaborative effort involved scientists from Immanuel Kant Baltic Federal University and Siberian State Medical University, with additional contributions from Saint Petersburg State University as part of a broader project. Their research focused on understanding how coating composition influences both the functional properties of the material and cellular responses. Hydroxyapatite was selected as the base due to its calcium phosphate structure, which closely resembles the mineral component of human bone. During the coating process, nitrogen exposure was systematically varied to assess its impact on the final material characteristics.
Further research will explore long-term biological effects
The research team plans to conduct additional laboratory and biological experiments beyond the initial seven-day period, with goals including tracking stem cell behavior over intervals between 10 and 28 days and evaluating the rate at which coatings dissolve over time. A further aspect of their ongoing work will involve monitoring nitric oxide release into tissue in live organisms, although these experiments were not part of the published study. Currently, the findings are confined to laboratory measurements, coated titanium samples, and controlled cell cultures, with no data on clinical application.
This investigation contributes valuable insights into how the ratios of nitrogen and argon influence calcium phosphate coatings for titanium implants, documenting effects on coating thickness, density, hardness, chemical bonds, and cellular responses. Under the tested conditions, coated samples consistently supported improved stem-cell survival compared to untreated titanium. It is important to note that these results are preclinical, and no claims regarding safety or efficacy in human patients can be made at this stage. Future studies are expected to examine properties not covered here, such as long-term cell behavior and nitric oxide release into tissues.